Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 7:28 pm Purchase |
2023-02-10 | 13G | IGM Biosciences, Inc. IGMS |
Artal Participations S.a r.l | 2,450,000 8.400% |
950,000 (+63.33%) |
Filing History |
| 2023-02-10 7:28 pm Purchase |
2022-12-31 | 13G | Aravive, Inc. ARAV |
Artal Participations S.a r.l | 12,182,037 9.900% |
10,870,746 (+829.01%) |
Filing History |
| 2023-02-10 7:25 pm Sale |
2022-12-31 | 13G | BELLUS Health Inc. BLU |
Artal Participations S.a r.l | 3,700,000 2.900% |
-4,800,000 (-56.47%) |
Filing History |
| 2023-02-10 7:21 pm Unchanged |
2022-12-31 | 13G | Aptinyx Inc. APTX |
Artal Participations S.a r.l | 6,116,493 9.000% |
0 (Unchanged) |
Filing History |
| 2023-02-10 7:21 pm Unchanged |
2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Artal Participations S.a r.l | 15,066,043 5.600% |
0 (Unchanged) |
Filing History |
| 2023-02-10 7:15 pm Unchanged |
2022-12-31 | 13G | Achilles Therapeutics plc ACHL |
Artal Participations S.a r.l | 2,255,375 5.500% |
0 (Unchanged) |
Filing History |
| 2023-02-01 4:30 pm Purchase |
2023-01-23 | 13G | Agenus Inc. AGEN |
Artal Participations S.a r.l | 796,411 5.100% |
796,411 (New Position) |
Filing History |
| 2022-08-23 4:16 pm Purchase |
2022-08-16 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 2,285,574 6.400% |
2,285,574 (New Position) |
Filing History |
| 2022-08-05 4:31 pm Purchase |
2022-07-28 | 13G | AlloVir, Inc. ALVR |
Artal Participations S.a r.l | 242,486 6.000% |
242,486 (New Position) |
Filing History |
| 2022-06-24 4:20 pm Purchase |
2022-06-22 | 13G | Scholar Rock Holding Corporation SRRK |
Artal Participations S.a r.l | 10,325,042 19.400% |
7,875,042 (+321.43%) |
Filing History |
| 2022-02-11 06:47 am Sale |
2021-12-31 | 13G | Seer, Inc. SEER |
Artal Participations S.a r.l | 4,750,000 8.300% |
-1,090,911 (-18.68%) |
Filing History |
| 2022-02-11 06:40 am Purchase |
2021-12-31 | 13G | BELLUS Health Inc. BLU |
Artal Participations S.a r.l | 8,500,000 8.200% |
3,750,000 (+78.95%) |
Filing History |
| 2022-02-11 06:38 am Purchase |
2022-02-11 | 13G | IGM Biosciences, Inc. IGMS |
Artal Participations S.a r.l | 1,500,000 5.800% |
175,000 (+13.21%) |
Filing History |
| 2022-02-11 06:35 am Purchase |
2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal Participations S.a r.l | 138,956 6.400% |
48,077 (+52.90%) |
Filing History |
| 2022-02-11 06:33 am Unchanged |
2021-12-31 | 13G | Generation Bio Co. GBIO |
Artal Participations S.a r.l | 2,814,191 4.900% |
0 (Unchanged) |
Filing History |
| 2022-02-11 06:31 am Purchase |
2021-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Artal Participations S.a r.l | 2,450,000 7.000% |
350,000 (+16.67%) |
Filing History |
| 2022-02-11 06:30 am Purchase |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
Artal Participations S.a r.l | 400,000 4.500% |
100,000 (+33.33%) |
Filing History |
| 2022-02-11 06:29 am Sale |
2021-12-31 | 13G | Morphic Holding, Inc. MORF |
Artal Participations S.a r.l | 1,585,049 4.300% |
-66,637 (-4.03%) |
Filing History |
| 2022-02-11 06:28 am Purchase |
2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 350,000 5.600% |
350,000 (New Position) |
Filing History |
| 2022-02-11 06:27 am Purchase |
2021-12-31 | 13G | Nanobiotix S.A. NBTX |
Artal Participations S.a r.l | 3,069,034 8.800% |
1,036,556 (+51.00%) |
Filing History |